- Home
- LNTH vs CSAN Comparison
LNTH vs CSAN Comparison
Compare LNTH & CSAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- CSAN
- Stock Information
- Founded
- LNTH 1956
- CSAN 1936
- Country
- LNTH United States
- CSAN Brazil
- Employees
- LNTH N/A
- CSAN N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CSAN Retail-Auto Dealers and Gas Stations
- Sector
- LNTH Health Care
- CSAN Consumer Discretionary
- Exchange
- LNTH Nasdaq
- CSAN Nasdaq
- Market Cap
- LNTH 3.8B
- CSAN 4.4B
- IPO Year
- LNTH 2015
- CSAN N/A
- Fundamental
- Price
- LNTH $58.45
- CSAN $4.96
- Analyst Decision
- LNTH Buy
- CSAN Hold
- Analyst Count
- LNTH 6
- CSAN 3
- Target Price
- LNTH $74.17
- CSAN $9.47
- AVG Volume (30 Days)
- LNTH 1.3M
- CSAN 2.8M
- Earning Date
- LNTH 11-06-2025
- CSAN 11-14-2025
- Dividend Yield
- LNTH N/A
- CSAN N/A
- EPS Growth
- LNTH N/A
- CSAN N/A
- EPS
- LNTH 2.39
- CSAN N/A
- Revenue
- LNTH $1,525,933,000.00
- CSAN $7,988,294,917.00
- Revenue This Year
- LNTH N/A
- CSAN $271.64
- Revenue Next Year
- LNTH $1.98
- CSAN $1.43
- P/E Ratio
- LNTH $24.55
- CSAN N/A
- Revenue Growth
- LNTH 1.95
- CSAN 2.13
- 52 Week Low
- LNTH $47.25
- CSAN $3.80
- 52 Week High
- LNTH $111.29
- CSAN $7.75
- Technical
- Relative Strength Index (RSI)
- LNTH 61.44
- CSAN 58.28
- Support Level
- LNTH $51.84
- CSAN $4.65
- Resistance Level
- LNTH $57.35
- CSAN $4.79
- Average True Range (ATR)
- LNTH 2.31
- CSAN 0.27
- MACD
- LNTH 0.60
- CSAN -0.01
- Stochastic Oscillator
- LNTH 93.11
- CSAN 56.73
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.